Biomedical research

In recent years, SMA®-based copolymers (SMALP) have proven their importance for directly solubilizing native lipid-protein complexes from a wide range of cell types or raw membranes. Our ready-to-use SMA® solutions are fully licensed for solubilizing membrane proteins in their native environment, enabling effective biomedical research.

Specifically, we have licenses to use SMA® for the solubilizing of membrane proteins from Malvern Cosmeceutics Limited (US8623414, EP1890675, GB2426703, AU2006253886, JP5142898 IN261468, CN ZL200680018957.2, CA 2611144) and the University of Birmingham (US8754168).

Look at the FAQ